Patrycja Kłaput
About Patrycja Kłaput
Patrycja Kłaput is a Drug Safety Manager and Project Lead at TFS Trial Form Support, where she has worked since 2019. She has a background in pharmacovigilance and medical advising, with previous roles at GSK and Sanofi.
Current Role at TFS HealthScience
Patrycja Kłaput serves as a Drug Safety Manager and Project Lead at TFS Trial Form Support since 2019. In this role, she oversees drug safety operations and leads various projects within the organization. Her responsibilities include ensuring compliance with safety regulations and managing risk assessment processes. Kłaput's expertise contributes to the overall safety management of clinical trials.
Previous Experience in Drug Safety
Before her current position, Kłaput worked as a Drug Safety Officer at TFS Trial Form Support from 2018 to 2019. In this role, she was involved in monitoring and reporting adverse events, ensuring that safety data was accurately captured and communicated. Her experience in this position laid the groundwork for her advancement to a managerial role.
Background in Medical Advisory
Kłaput began her career as a Medical Advisor Assistant in the OTC division at Sanofi in 2013. This role lasted for five months and provided her with foundational experience in the pharmaceutical industry, particularly in understanding the regulatory landscape and product safety.
Education and Academic Qualifications
Kłaput holds a Bachelor of Engineering degree from the Silesian University of Technology, which she completed from 2008 to 2012. She furthered her education by obtaining a Master's degree from Warsaw University of Technology from 2012 to 2013. Additionally, she studied at the Medical University of Łódź from 2014 to 2015, enhancing her knowledge in medical sciences.
Experience in Pharmacovigilance
From 2015 to 2018, Kłaput worked as a Pharmacovigilance Specialist in the Global Safety and Pharmacovigilance Department at GSK in Hayes, Hillingdon, United Kingdom. During this three-year tenure, she focused on monitoring drug safety and managing adverse event reports, contributing to the safety profile of pharmaceutical products.